Tirzepatide (GLP-2)
$44.99
Tirzepatide is a revolutionary dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. FDA-approved for both type 2 diabetes management and chronic weight management, it has demonstrated unprecedented efficacy for weight loss and metabolic health optimization. Tirzepatide works by mimicking incretin hormones that regulate blood sugar, slow gastric emptying, and reduce appetite, offering superior results compared to single-mechanism GLP-1 agonists.
Usage Disclaimer: Research Use Only. This product is intended strictly for laboratory research and in-vitro studies. It is not for human or animal consumption, medical use, or diagnostic purposes. Any unauthorized use of this product is strictly prohibited.
FDA Compliance: FDA Notice. The statements made regarding these products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Research Studies
SURMOUNT-2 T2DM Trial (2023)
938 adults with T2DM and obesity | 72-week duration
15mg dose achieved 15.7% weight loss with significant improvements in all cardiometabolic parameters
SURPASS-CVOT Cardiovascular Outcomes (2023)
12,785 T2DM patients | 3.5-year follow-up | Primary prevention study
26% reduction in major adverse cardiovascular events, establishing cardioprotective benefits
SURMOUNT-1 Phase 3 Trial (2022)
2,539 adults with obesity | 72-week study | Multiple dose levels
15mg weekly dose achieved 22.5% weight loss vs 2.4% placebo - largest weight loss seen in pharmaceutical trials
Pair your peptide order with bacteriostatic water for proper reconstitution and storage. Adding it now ensures you have everything you need when your order arrives.
Avoid delays and complete your setup in one shipment.
